Case Report: unmasking pseudo-homozygosity in CYP21A2: intergenerational gene conversion expansion and the necessity of multimodal genetic testing - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Case Study: Revealing Pseudo-Homozygosity in CYP21A2 Through Intergenerational Gene Conversion Expansion and the Importance of Comprehensive Genetic Testing

  • By

  • Zuhal Altintas

  • Sefanur Karaca

  • Ayhan Coskun

  • August 18, 2026

Share

Original Source(s)

Case Report: unmasking pseudo-homozygosity in CYP21A2: intergenerational gene conversion expansion and the necessity of multimodal genetic testing

  • by Zuhal Altintas, Sefanur Karaca, Ayhan Coskun

  • August 18, 2026

Related Content

How Often Is Thyroid Hormone Needed After Hemithyroidectomy?

Nearly 40% of patients initiated thyroid hormone therapy within 2 years of hemithyroidectomy, with higher preoperative thyroid‐stimulating hormone levels and thyroid cancer identifying those at greatest risk.

Can GH therapy improve final height after HCT?

Growth gains continued beyond the first year of treatment, while irradiation and other transplant-related factors influenced response.

CHEST Issues OSA Guidance for Pregnancy

Guideline recommends screening, diagnosis, positive airway pressure therapy, and postpartum reassessment while highlighting the very low certainty of available evidence.